Registered entities
Clearside Biomedical, Inc.
Reg. No. 1539029United States
Clearside Holdings ApS
Reg. No. 38451928Denmark
Innovation
31 patent families (15 granted) — focus: Human necessities, Physics & computing; filing pace slowing. Cited 16,681 times.
| Year | Filings |
|---|---|
| 2015 | 5 |
| 2016 | 7 |
| 2017 | 12 |
| 2018 | 10 |
| 2019 | 14 |
| 2020 | 9 |
| 2021 | 12 |
| 2022 | 9 |
| 2023 | 11 |
| 2024 | 10 |
| 2025 | 11 |
| 2026 | 2 |
Social engagement
Social engagement: 3.4K social following, 4 posts in the last 12 months — top quartile of its industry.
Investor mix
12 investors on record; lead investors include Perceptive Advisors, Rock Springs Capital, Aju IB Investment, Hatteras Venture Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 9 | 75% |
| Private equity | 1 | 8% |
| Accelerator & incubator | 1 | 8% |
| Other / undisclosed | 1 | 8% |
Recent activity
26 Aug 2025
Event
25th European Society of Retina Specialists (EURETINA) Congress
23 Jul 2025
Product launch
XIPERE® Surachoroidal Treatment for Uveitic Macular Edema
17 Jul 2025
Partnership
ClearsideBio